论文部分内容阅读
目的:观察依达拉奉联合川穹嗪治疗急性脑梗死的临床疗效。方法:分别用依达拉奉联合川穹嗪(观察组)和维脑路通(对照组)治疗急性脑梗死(ACI)患者,比较其临床疗效及血液流变学参数。结果:观察组总有效率高于对照组(P<0.05);两组血液流变学指标均改善,尤以观察组改善明显(P<0.05)。结论:提示依达拉奉联合川穹嗪治疗ACI疗效优于维脑路通。
Objective: To observe the clinical efficacy of edaravone and lamivudine in the treatment of acute cerebral infarction. Methods: Patients with acute cerebral infarction (ACI) were treated with edaravone combined with chlortanidase (observation group) and Wei Lutong Tong (control group) respectively, and their clinical effects and hemorheological parameters were compared. Results: The total effective rate in the observation group was higher than that in the control group (P <0.05). The indexes of hemorheology were improved in both groups, especially in the observation group (P <0.05). Conclusion: It is suggested that the effect of edaravone and lamivudine on ACI is better than that of Viagra.